Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Update

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 9,900 shares, an increase of 37.5% from the January 31st total of 7,200 shares. Based on an average daily trading volume, of 837,800 shares, the short-interest ratio is currently 0.0 days. Approximately 2.3% of the company’s stock are sold short.

Avalon GloboCare Trading Up 24.3 %

Shares of NASDAQ:ALBT opened at $9.01 on Tuesday. The stock has a fifty day simple moving average of $4.09 and a two-hundred day simple moving average of $3.69. Avalon GloboCare has a 12-month low of $2.11 and a 12-month high of $21.60. The stock has a market capitalization of $9.86 million, a price-to-earnings ratio of -0.45 and a beta of 0.19.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.